New imaging technology for identifying breast cancer and lymph node status

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the use of near-infrared-II (NIR-II) fluorescent molecular probes to accurately identify breast cancer tissue and assess sentinel lymph node (SLN) metastatic status during surgery. Patients undergoing surgical treatment for breast cancer will have their excised tissues incubated with a specific probe, followed by imaging to differentiate between cancerous and normal tissues. The accuracy of the imaging results will be confirmed through pathological examination, aiming to improve surgical outcomes and reduce the need for additional operations.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult patients between 18-75 years of age
* Female
* Patients presenting with a breast nodule or mass presumed to be resectable on pre-operative assessment
* Good operative candidate
* Subject capable of giving informed consent and participating in the process of consent

Exclusion Criteria:

* Patients unable to participate in the consent process
* Patients had contraindications to surgery, such as serious cardiopulmonary disease, coagulation dysfunction, etc
* Other conditions that the researcher considers inappropriate to participate in the study

Where it's running

• Yunnan Cancer Hospital
  Kunming, Yunnan, China Recruiting

Study contacts

• Study coordinator: Yuanyuan Zhu,Doctor
• Email: 18059766094@163.com
• Phone: 86+18059766094

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Spectral tissue recognition for detecting cancer at breast lumpectomy margins

  This project will test whether a handheld spectral device with AI can tell cancerous from healthy breast tissue during breast-conserving surgery in adults with confirmed breast cancer.

  Recruiting Spctr · Groningen, Provincie Groningen and 1 other locations · NCT07459062

• Using indocyanine green to find sentinel lymph nodes during mastectomy

  This pilot will test whether injecting indocyanine green and using fluorescence during mastectomy can find sentinel lymph nodes in women with clinically node-negative invasive breast cancer.

  Recruiting at 2 sites St. Antonius Hospital · Zwolle, Overijssel and 1 other locations · NCT07362485

• Using indocyanine green to identify sentinel lymph nodes during breast cancer surgery

  This project tests whether indocyanine green dye and a fluorescence camera can be used instead of the radioactive tracer to find sentinel lymph nodes in adults having breast cancer surgery who are clinically node-negative.

  Recruiting at 7 sites St. Antonius Hospital · Alkmaar and 6 other locations · NCT07146295

• Using advanced imaging technology for early-stage breast cancer surgery

  This study is testing a new imaging tool during breast cancer surgery to see if it can help doctors find lymph nodes more accurately and improve treatment for patients.

  Recruiting Fudan University · Shanghai, Shanghai Municipality · NCT06911528

• Tailoring axillary surgery for breast cancer patients

  This study is testing if some early breast cancer patients can skip certain surgeries to remove lymph nodes, which might help them avoid unnecessary complications and costs.

  Recruiting KK Women's and Children's Hospital · Singapore · NCT06259513

• Using a low dose of Magtrace to locate lymph nodes in breast cancer patients

  This study is testing if a low dose of a new tracer can help find lymph nodes in breast cancer patients as well as the traditional methods do.

  Recruiting Phase 2 Vastra Gotaland Region · Gothenburg · NCT06169072

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.